Myoguide Guidance for Botulinum Toxin Injections
PRESS: MYOGUIDE GUIDANCE FOR BOTULINUM TOXIN INJECTIONS |
| Myoguide presents a comprehensive integrated system that was developed to better satisfy the needs of leading Neurologists, Physiatrists and clinicians injecting neuromodulators such as: Botox©, Myobloc©, Dysport©, and Xeomin© for the management of pain, movement disorders, and spastic muscle |
| Date Released: 08/22/2010 |
 Therapy with botulinum toxin should be individualized for the patient and the clinician. The equipment needs should be determined according to the needs of the patient, the clinician’s training, and the anatomic target for injection. Myoguide is an essential tool for neuromodulator injections.
Use of electromyography, or motor point stimulation (e-stim/ stimulation location), is recommended to identify muscles . For example, the flexor digitorum sublimis (FDS), is nearly impossible to locate without electromyographic guidance. This is especially so for the clinician who is developing his or her skills in identifying specific muscles for injection with botulinum toxin, the use of Myoguide may enhance the clinician’s understanding of functional anatomy and aid the clinician in making decisions on injection localization. For muscles requiring electromyographic guidance, a hypodermic needle electrode, through which botulinum toxin can be injected, is used. Surface reference and ground electrodes should be placed near the injection point. Intronix Technologies is pleased to present Myoguide. Visit www.intronixtech.com for a wealth of information on injection guidance, including billing. Myoguide provides a superior injection site targeting system with many useful features, such as, the ability to see and hear EMG signals, display real time analyzed EMG, and stimulation location capability. There are numerous advantages to embracing Myoguide for injection guidance: • Conveniently integrated into one handheld package • Helps identify involved muscles i.e. pre-injection physiopathological evaluation, or pre-intervention evaluation. (Either by EMG or stimulation location) • pre-injection evaluation in cases where the site may be surrounded by essential nerves and blood vessels • pre-injection evaluation can lead to reduced drug dose and volume, thereby reducing the incidence of drug resistance, and limiting drug diffusion into adjacent areas. • Provides confirmation of treatment effects The need to increase accuracy when injecting neuromodulators has been highlighted by recent FDA reviews of the dangers of peripheral effects. Use of Myoguide can lead to more accurate injection site targeting, allowing reduced concentrations and volumes of inject See Myoguide at The AANEM meeting in Quebec City, October 6-9, 2010 Booth #212, and MEDICA 2010, in Dusseldorf, Germany: Hall 16, Booth 16G42, November 17-20, 2010. |